Product Information
QC ANTI-NAUSEA LIQUID is a generic product labeled by Chain Drug Marketing Association, priced at $0.0235 per ML under NDC 83324021704. Its NADAC has been published 88 times since Jan 29, 2025.
Strength
1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324021704
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACIDApproval Type
Unapproved
On Market Since
4/16/2019
Price Statistics
The NADAC for QC ANTI-NAUSEA LIQUID has been published 88 times since Jan 29, 2025, and over the history we have for it it has risen 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0235 per ML |
|---|---|
| All-time high | $0.0239 (Jun 10, 2026) |
| All-time low | $0.0202 (Jan 29, 2025) |
| 52-week high | $0.0239 |
| 52-week low | $0.0218 |
| Median price | $0.0223 |
| Average price | $0.0222 |
| Largest weekly change | +3.1% (Oct 22, 2025) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextrose(glucose),Levulose(fructose),Phosphoric acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextrose(glucose),Levulose(fructose),Phosphoric acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ANTI-NAUSEA LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for QC ANTI-NAUSEA LIQUID, manufactured by Chain Drug Marketing Association, is $0.0235 per ML (NDC 83324021704), effective Sep 30, 2026.
How has the price of QC ANTI-NAUSEA LIQUID changed over time?
Over the history we have for it, the NADAC for QC ANTI-NAUSEA LIQUID has risen 16.3%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for QC ANTI-NAUSEA LIQUID?
Since Jan 29, 2025, the NADAC for QC ANTI-NAUSEA LIQUID has ranged from a low of $0.0202 (Jan 29, 2025) to a high of $0.0239 (Jun 10, 2026), with a median of $0.0223 per ML.
Are there cheaper alternatives to QC ANTI-NAUSEA LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of QC ANTI-NAUSEA LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC ANTI-NAUSEA LIQUID?
QC ANTI-NAUSEA LIQUID (NDC 83324021704) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.